Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ADUSNYSE:ARDTNASDAQ:PGNYNASDAQ:TALK On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeADUSAddus HomeCare$115.12-0.4%$110.24$88.96▼$136.72$2.12B0.81165,890 shs285,580 shsARDTArdent Health$13.69+2.9%$13.75$11.31▼$20.72$1.96BN/A382,511 shs827,810 shsPGNYProgyny$21.91+2.1%$21.84$13.39▼$30.42$1.88B1.321.70 million shs2.65 million shsTALKTalkspace$2.77+0.7%$3.00$1.60▼$4.36$463.48M1.121.88 million shs1.95 million shsInvesting Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceADUSAddus HomeCare0.00%+1.17%+2.50%+16.41%-0.85%ARDTArdent Health0.00%+5.11%-5.46%-0.62%+1,368,999,900.00%PGNYProgyny0.00%+4.43%+0.23%-1.92%-23.42%TALKTalkspace0.00%+3.36%-13.98%+8.20%+20.43%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationADUSAddus HomeCare4.736 of 5 stars2.65.00.05.01.82.52.5ARDTArdent Health3.2653 of 5 stars3.50.00.00.01.90.03.1PGNYProgyny1.0759 of 5 stars1.22.00.00.02.12.51.3TALKTalkspace4.1933 of 5 stars3.54.00.00.03.73.31.9Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceADUSAddus HomeCare 3.25Buy$142.5723.85% UpsideARDTArdent Health 3.00Buy$20.6750.96% UpsidePGNYProgyny 2.42Hold$23.457.05% UpsideTALKTalkspace 3.00Buy$4.5062.45% UpsideCurrent Analyst Ratings BreakdownLatest TALK, PGNY, ADUS, and ARDT Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/20/2025ADUSAddus HomeCareJMP SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingMarket Outperform ➝ Market Outperform$150.006/10/2025ADUSAddus HomeCareMacquarieSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Outperform$133.005/20/2025ARDTArdent HealthStephensSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Overweight$21.00 ➝ $21.005/15/2025ARDTArdent HealthRoyal Bank Of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Outperform$21.00 ➝ $21.005/12/2025PGNYProgynyCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetHold ➝ Hold$23.00 ➝ $21.005/9/2025ARDTArdent HealthGuggenheimSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$16.00 ➝ $18.005/8/2025ADUSAddus HomeCareMacquarieSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$129.00 ➝ $133.005/6/2025TALKTalkspaceNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingHold ➝ Hold4/22/2025ADUSAddus HomeCareJMP SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingMarket Outperform ➝ Market Outperform$150.00 ➝ $150.004/10/2025ADUSAddus HomeCareJMP SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingMarket Outperform ➝ Market Outperform$150.00 ➝ $150.004/9/2025ARDTArdent HealthGuggenheimSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$16.00(Data available from 6/30/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookADUSAddus HomeCare$1.15B1.83$5.39 per share21.36$53.52 per share2.15ARDTArdent Health$6.02B0.33$2.54 per share5.39$10.66 per share1.28PGNYProgyny$1.17B1.61$0.35 per share63.49$4.96 per share4.42TALKTalkspace$187.59M2.47$0.01 per share233.14$0.69 per share4.01Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateADUSAddus HomeCare$73.60M$4.4325.9921.481.636.52%9.23%6.96%8/4/2025 (Estimated)ARDTArdent Health$210.34M$1.638.406.981.243.73%16.07%4.69%8/13/2025 (Estimated)PGNYProgyny$54.34M$0.5738.4433.712.304.33%10.90%7.20%8/5/2025 (Estimated)TALKTalkspace$1.15M$0.02138.5714.58N/A1.51%2.54%2.15%8/5/2025 (Estimated)Latest TALK, PGNY, ADUS, and ARDT EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/8/2025Q1 2025PGNYProgyny$0.45$0.17-$0.28$0.17$307.86 million$324.04 million5/6/2025Q1 2025ARDTArdent Health$0.21$0.29+$0.08$0.29$1.50 billion$1.50 billion5/5/2025Q1 2025ADUSAddus HomeCare$1.33$1.42+$0.09$1.16$341.66 million$337.71 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthADUSAddus HomeCareN/AN/AN/AN/AN/AARDTArdent HealthN/AN/AN/AN/AN/APGNYProgynyN/AN/AN/AN/AN/ATALKTalkspaceN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioADUSAddus HomeCare0.201.741.74ARDTArdent Health0.702.121.98PGNYProgynyN/A2.392.39TALKTalkspaceN/A6.496.49Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipADUSAddus HomeCare95.35%ARDTArdent HealthN/APGNYProgyny94.93%TALKTalkspace57.37%Insider OwnershipCompanyInsider OwnershipADUSAddus HomeCare4.60%ARDTArdent Health1.70%PGNYProgyny9.40%TALKTalkspace23.50%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableADUSAddus HomeCare49,70318.40 million17.55 millionOptionableARDTArdent Health24,900143.04 million140.61 millionOptionablePGNYProgyny31085.72 million77.66 millionOptionableTALKTalkspace500167.32 million128.00 millionOptionableTALK, PGNY, ADUS, and ARDT HeadlinesRecent News About These CompaniesTalkspace, Inc. (NASDAQ:TALK) Given Consensus Recommendation of "Buy" by BrokeragesJune 22, 2025 | marketbeat.comTalkspace (NASDAQ:TALK) Shares Up 5.2% - Still a Buy?June 11, 2025 | marketbeat.comTalkspace (NASDAQ:TALK) Shares Gap Down - Should You Sell?June 10, 2025 | marketbeat.comSquarepoint Ops LLC Lowers Stake in Talkspace, Inc. (NASDAQ:TALK)June 10, 2025 | marketbeat.comInsider Selling: Talkspace, Inc. (NASDAQ:TALK) CMO Sells 39,000 Shares of StockJune 7, 2025 | insidertrades.comKatelyn Watson Sells 39,000 Shares of Talkspace, Inc. (NASDAQ:TALK) StockJune 6, 2025 | marketbeat.comTalkspace to Participate in Upcoming Investor ConferencesJune 6, 2025 | globenewswire.comTalkspace And 2 Other Compelling Penny Stocks To ConsiderJune 5, 2025 | finance.yahoo.comTalkspace (NASDAQ:TALK) Stock Price Down 4.4% - What's Next?June 4, 2025 | marketbeat.comNuveen Asset Management LLC Boosts Holdings in Talkspace, Inc. (NASDAQ:TALK)June 4, 2025 | marketbeat.comTwo Sigma Advisers LP Decreases Holdings in Talkspace, Inc. (NASDAQ:TALK)June 3, 2025 | marketbeat.comTwo Sigma Investments LP Buys 82,921 Shares of Talkspace, Inc. (NASDAQ:TALK)June 2, 2025 | marketbeat.comMillennium Management LLC Boosts Holdings in Talkspace, Inc. (NASDAQ:TALK)May 31, 2025 | marketbeat.comTalkspace (NASDAQ:TALK) Shares Gap Up - Still a Buy?May 30, 2025 | marketbeat.comShares of Talkspace Climb After Amazon Pharmacy PartnershipMay 29, 2025 | marketwatch.comNew York banning smart phones in schoolMay 18, 2025 | msn.comDigital health companies faced a rocky start to 2025May 9, 2025 | modernhealthcare.comMMental Health and Substance Misuse Treatment Is Increasingly a Video Chat or Phone Call AwayMay 9, 2025 | californiahealthline.orgC'Bachelor in Paradise' 2025: Palm Desert's Gary Levingston talks cast, Talkspace collabMay 9, 2025 | palmbeachpost.comPTalkspace: Great Value For A Tariff-Resistant BusinessMay 8, 2025 | seekingalpha.comEarnings call transcript: Talkspace Q1 2025 reports revenue growth, stock fallsMay 8, 2025 | uk.investing.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesIPO Momentum Returns: 3 Stocks Rising After CoreWeave’s SurgeBy Dan Schmidt | June 20, 2025View IPO Momentum Returns: 3 Stocks Rising After CoreWeave’s SurgeBigBear.ai Poised to Benefit as Palantir Dominates AI DefenseBy Gabriel Osorio-Mazilli | June 23, 2025View BigBear.ai Poised to Benefit as Palantir Dominates AI DefenseIntel's Turnaround Strategy Shifts From Planning to Attack ModeBy Jeffrey Neal Johnson | June 20, 2025View Intel's Turnaround Strategy Shifts From Planning to Attack ModeChina Market Movers: MCHI, PDD, BIDU Show Bullish TrendsBy Gabriel Osorio-Mazilli | June 16, 2025View China Market Movers: MCHI, PDD, BIDU Show Bullish TrendsTariff Talks Advance, What Taiwan Semiconductor Can DeliverBy Gabriel Osorio-Mazilli | June 16, 2025View Tariff Talks Advance, What Taiwan Semiconductor Can DeliverTALK, PGNY, ADUS, and ARDT Company DescriptionsAddus HomeCare NASDAQ:ADUS$115.12 -0.52 (-0.45%) Closing price 06/27/2025 04:00 PM EasternExtended Trading$111.74 -3.38 (-2.94%) As of 04:23 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living. This segment offers services that include assistance with bathing, grooming, oral care, feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services. The Hospice segment provides palliative nursing care, social work, spiritual counseling, homemaker, and bereavement counseling services for people who are terminally ill, as well as related services for their families. The Home Health segment offers skilled nursing and physical, occupational, and speech therapy for the individuals who requires assistance during an illness or after hospitalization. The company's payor clients include federal, state, and local governmental agencies; managed care organizations; commercial insurers; and private individuals. Addus HomeCare Corporation was founded in 1979 and is headquartered in Frisco, Texas.Ardent Health NYSE:ARDT$13.69 +0.38 (+2.85%) Closing price 06/27/2025 03:59 PM EasternExtended Trading$13.88 +0.19 (+1.39%) As of 04:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Ardent Health Partners, Inc. owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee. Ardent Health Partners, Inc. is a subsidiary of EGI-AM Investments, L.L.C.Progyny NASDAQ:PGNY$21.91 +0.45 (+2.10%) Closing price 06/27/2025 04:00 PM EasternExtended Trading$22.48 +0.57 (+2.62%) As of 04:30 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.Talkspace NASDAQ:TALK$2.77 +0.02 (+0.73%) Closing price 06/27/2025 04:00 PM EasternExtended Trading$2.83 +0.06 (+2.17%) As of 04:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Talkspace, Inc. operates as a virtual behavioral healthcare company in the United States. The company offers psychotherapy and psychiatry services through its platform to individuals, enterprises, and health plans and employee assistance programs. It provides text, audio, and video-based psychotherapy from licensed therapists. The company offers Talkspace Employee Assistance Program (EAP) and Talkspace Behavioral Health plan (BH) that provides online therapy to members through BH and EAP offerings; and Talkspace for Business for members to access its platform services on a benefit plan paid by the enterprise. It serves its platform through third-party platforms or marketplace, such as Apple App Store and Google Play App Store. Talkspace, Inc. was founded in 2012 and is headquartered in New York, New York. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Nike Stock: The Mother of All Comebacks Might Have Just Begun EA Just Caught a Monster Upgrade: Bullish Breakout Ahead? Snowflake Hits 52-Week High—Options Traders Bet on Further Rally Addition by Subtraction: Intel’s New Strategy Energizes Investors Apple: The Mag 7’s Dead Money Stock or AI Cash Cow in the Making? NVIDIA’s Stock Price Hits New Highs: This Is What’s Next Micron: A Hot Buy Heats Up, Fresh All-Time Highs Are Coming Rocket Lab: Europe Comes Calling as Momentum Builds Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
